Collaborate with the Functional
MRC · United Kingdom
Opportunity to collaborate with the Functional Genomics Screening Laboratory (FGSL) on projects using complex human in vitro models for CRISPR screening to better understand model biology and enable target identification.
Overview
Opportunity to collaborate with the Functional Genomics Screening Laboratory (FGSL) on projects using complex human in vitro models for CRISPR screening to better understand model biology and enable target identification.
Grant details
Application Platform: Application form submitted through Connect: Health Tech at the University of Cambridge and emailed to the programme team.
Application Sections: Application form including details about the in vitro model, desired screen, and endpoint assay.
Assessment Process: Applications are assessed by a Joint Steering Committee with representatives from MRC, AstraZeneca, and the Milner Therapeutics Institute.
Co-Funders: AstraZeneca; University of Cambridge
Collaboration Rules: Projects must be collaborative with the Functional Genomics Screening Laboratory. Screens are carried out by scientists at the Milner Therapeutics Institute but conducted in collaboration with the proposing research team.
Competitiveness: Not specified
Consortium Requirements: Not specified
Decision Risks: Applications may be rejected if the proposed biological model is unsuitable for CRISPR screening or if feasibility requirements are not met.
Decision Timeline: Applications are reviewed approximately twice per year by the Joint Steering Committee.
Eligible Expenses: Consumables for screens may be funded either by AstraZeneca where the model is of interest to AstraZeneca or through a screening access fund provided by MRC.
Eligible Scope: Projects using complex human in vitro models to conduct arrayed CRISPR screening for biological investigation and target identification.
Funding Intensity: Not specified
Important Notes: The Functional Genomics Screening Laboratory is a joint initiative between MRC, AstraZeneca, and the Milner Therapeutics Institute to provide access to advanced CRISPR screening capabilities for UK researchers.
Ineligible Projects: Not specified
International Collaboration Requirement: Not specified
Interview Stage: Not specified
Key Requirements: Applicants must provide detailed information about the model used, screening design, and endpoint assays.
Lead Organisation Requirement: Not specified
Match Funding Requirement: Not specified
Project Duration: Determined on a case-by-case basis depending on the model, its expansion capacity, and the size of the proposed screen
Project End Date: Not specified
Project Start Date: Not specified
Publication Date: 2024-04-18 00:00:00
Renewal Rules: Not specified
Research Category: Functional genomics research collaboration.
Research Organisation Funding: Not specified
Subcontractors: Not specified
Total Fund Available: Not specified
Quick facts
- Status
- Open
- Closing date
- Rolling
- Funding amount
- Amount not specified
- Funding type
- Procurement/Other
- Audience
- Business
- Industry
- Health & Life Sciences, Creative & Cultural